Record NASDAQ is Good News for Our Members New never seen before, tiny float, recent IPO Report that you do NOT want to miss coming tomorrow 8-7-20 at...
Our Recently Reported on Stocks Subsequently Featured on “The Claman Countdown” on Fox Business
Three of our Recent Reported on Stocks Were Subsequently Featured on Fox Business. ShiftPixy (NASDAQ: PIXY), Vuzix Corp. (NASDAQ: VUZI) and Arcimoto (...
ViiV Healthcare Announces FDA Approval of an Expanded Indication for Dovato (dolutegravir/lamivudine), a Complete Two-Drug Regimen for Virologically Suppressed Adults with HIV-1
Article Link: ViiV Healthcare Announces FDA Approval of an Expanded Indication for Dovato (dolutegravir/lamivudine), a Complete Two-Drug Regimen for V...
FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Article Link: FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma ...
Potential FDA Approval Just Around the Corner for a Blockbuster Product (Mino-Lok) With Billion-Dollar Market Estimates
Citius Pharma (CTXR) Brings More Experts on Board CTXR looking ready to hit the gas Good day everyone, We are continuing our coverage of Citius Pharma...
FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
Article Link: FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex CARLSBAD, C...
FDA Approves Spravato (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
Article Link: FDA Approves Spravato (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Sui...
FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Article Link: FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-cel...
FDA Approves Genentech’s Tecentriq plus Cotellic and Zelboraf for People With Advanced Melanoma
Article Link: FDA Approves Genentech’s Tecentriq plus Cotellic and Zelboraf for People With Advanced Melanoma South San Francisco, CA ...
The Uber of Employment ShiftPixy, Inc. (NASDAQ: PIXY) Gig Economy, High Growth Report
ShiftPixy (PIXY) Exemplifies Innovation in a Pandemic BREAKING NEWS: ShiftPixy Labs may be a new vertical Good day everyone, We are initiating coverag...